HPV Screening Medicare Coverage Up For Consideration
This article was originally published in The Pink Sheet Daily
Executive Summary
CMS says it will consider whether to nationally cover a cervical cancer screening regimen that combines human papillomavirus testing with the standard Pap smear as an alternative to more frequent Pap smears in what could be a boost for HPV test makers.
You may also be interested in...
Roche’s HPV Test Approved As First-Line Cervical Cancer Screen
The firm’s cobas human papillomavirus test is the first to gain approved labeling as a primary screen. It could be a market advantage for Roche, but the company now needs to work with clinical guideline developers to put the approved indication into routine practice.
Massive Family Dollar Rat Infestation Leads To Multi-State Recall
The US FDA found more than 2,000 rats at an Arkansas Family Dollar distribution center, leadingto a six-state recall for products including feminine hygiene products, contact lens cleaners and face masks.
Digital Health Roundup: Exec Chats With Illumina, Bloom, AngelMed; M&A, Funding; FDA Down-Classifies Apps
In this roundup feature focusing on new developments in digital health, Medtech Insight spotlights IBM Watson Health’s divestiture and other financing news, Exec Chats with Illumina, AngelMed and Bloom, Philips’ new hand-held ultrasound device and autonomous robotic surgery, as well as the latest FDA news on digital health.